Study Results

Stay connected

February 12, 2016

CIHR-funded researcher's work on disrupting tumour growth appears in Cancer Cell

Dr. Jörg Stetefeld is part of a team whose work was featured in the most recent edition of Cancer Cell. The team's work revolved around studying a particular receptor found on proteins on our nerve cells. This receptor helps nerve cells send electrical impulses towards the rest of the body, helping us to experience things like the sensations of touch and warmth, for example. In studying this particular receptor, called UNC5, Dr. Stetefeld and the rest of the team discovered that by using an antibody to block the protein and its receptor from interacting, some tumour cells would lose their ability to grow, and would die off.

The team also experimented with ways to make tumour cells more susceptible to this antibody, opening the door to combining it with existing cancer drugs to create more effective therapies to stop tumours from growing.

Date modified: